Literature DB >> 3294291

Structure-function studies of human granulocyte-macrophage colony-stimulating factor. Identification of residues required for activity.

I Clark-Lewis1, A F Lopez, L B To, M A Vadas, J W Schrader, L E Hood, S B Kent.   

Abstract

Human granulocyte-macrophage colony stimulating factor (hGM CSF), a protein containing 127 amino acids, was chemically synthesized by using automated stepwise solid-phase methods. The unpurified synthetic hGM-CSF had the same range of actions on hemopoietic cells as the purified recombinant protein. The structural requirements for the activities of synthetic hGM-CSF were examined by the design and synthesis of fragments and analogs. The synthetic fragment, hGM-CSF (54-127), containing all four of the cysteine residues found in the intact protein, lacked detectable activity. Assays of fragments shortened at the N terminus showed that the residues 1-13 were not required for activity, but that the integrity of residues 14-25, particularly residues 16, 17, and 18, was critical for biologic activity. The 14-25 region is predicted to form the first alpha-helix in hGM-CSF. Synthetic peptides within the N-terminal 53 residue region lacked detectable activity. The synthetic analog hGM-CSF (1-121), which lacks the C-terminal 6 residues, had similar activity to hGM-CSF (1-127) indicating that residues 122-127 are not required for activity. An analog, [Ala88] hGM-CSF (14-96), which lacks the hydrophobic C-terminal region and 2 cysteine residues, had low but readily detectable activity suggesting that residues 14-96 are sufficient for detectable synthetic hGM-CSF activity, although the presence of residues 97-121 are required for full activity. No dissociation of the multiple biological activities of hGM-CSF was detected.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3294291

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Identification of critical regions in mouse granulocyte-macrophage colony-stimulating factor by scanning-deletion analysis.

Authors:  A B Shanafelt; R A Kastelein
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

2.  Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  Daniel H Doherty; Mary S Rosendahl; Darin J Smith; Jennifer M Hughes; Elizabeth A Chlipala; George N Cox
Journal:  Bioconjug Chem       Date:  2005 Sep-Oct       Impact factor: 4.774

3.  Glycosylation, disulfide bond formation, and the presence of a WSXWS-like motif in the orf virus GIF protein are critical for maintaining the integrity of Binding to ovine granulocyte-macrophage colony-stimulating factor and interleukin-2.

Authors:  C J McInnes; D Deane; D Haig; A Percival; J Thomson; A R Wood
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Defining the antigenic structure of human GM-CSF and its implications for receptor interaction and therapeutic treatments.

Authors:  Marcos Oggero; Ronald Frank; Marina Etcheverrigaray; Ricardo Kratje
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

5.  A human interleukin 3 analog with increased biological and binding activities.

Authors:  A F Lopez; M F Shannon; S Barry; J A Phillips; B Cambareri; M Dottore; P Simmons; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

6.  Granulocyte-macrophage colony-stimulating factor mimicry and receptor interactions.

Authors:  J M Von Feldt; C Monfardini; T Kieber-Emmons; D Voet; D B Weiner; W V Williams
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

7.  Hematopoietic activity of granulocyte/macrophage colony-stimulating factor is dependent upon two distinct regions of the molecule: functional analysis based upon the activities of interspecies hybrid growth factors.

Authors:  K Kaushansky; S G Shoemaker; S Alfaro; C Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

8.  Structure-function analysis of interleukin-5 utilizing mouse/human chimeric molecules.

Authors:  A N McKenzie; S C Barry; M Strath; C J Sanderson
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

9.  Crucial role of the residue R280 at the F'-G' loop of the human granulocyte/macrophage colony-stimulating factor receptor alpha chain for ligand recognition.

Authors:  D Rajotte; C Cadieux; A Haman; B C Wilkes; S C Clark; T Hercus; J A Woodcock; A Lopez; T Hoang
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

10.  Residue 21 of human granulocyte-macrophage colony-stimulating factor is critical for biological activity and for high but not low affinity binding.

Authors:  A F Lopez; M F Shannon; T Hercus; N A Nicola; B Cambareri; M Dottore; M J Layton; L Eglinton; M A Vadas
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.